Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 272.91M P/E - EPS this Y 38.30% Ern Qtrly Grth -
Income -78.9M Forward P/E -2.43 EPS next Y 18.00% 50D Avg Chg -23.00%
Sales 6.31M PEG - EPS past 5Y - 200D Avg Chg -26.00%
Dividend N/A Price/Book 2.22 EPS next 5Y - 52W High Chg -59.00%
Recommedations 1.70 Quick Ratio 1.83 Shares Outstanding 55.16M 52W Low Chg 28.00%
Insider Own 1.62% ROA -25.37% Shares Float 21.33M Beta 1.86
Inst Own 93.95% ROE -129.15% Shares Shorted/Prior 5.62M/5.61M Price 4.96
Gross Margin - Profit Margin - Avg. Volume 174,832 Target Price 11.14
Oper. Margin -776.95% Earnings Date Aug 6 Volume 93,236 Change -5.52%
About Omega Therapeutics, Inc.

Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by restoring aberrant gene expression to a range without altering native nucleic acid sequences. It also develops OTX-2002 for hepatocellular carcinoma; OTX-2101 for non-small cell lung cancer; omega epigenomic controllers (OEC) for inflammatory lung diseases, such as neutrophilic asthma, acute respiratory distress syndrome, dermatological, oncology, and rheumatological indications; OEC candidates for idiopathic pulmonary fibrosis; liver regeneration medicines; and OEC candidates for patients with diabetes and other conditions to treat corneal epithelial injury. In addition, the company develops OEC candidates for the treatment of alopecia, a disorder characterized by patches of non-scarring hair loss affecting the scalp and body. Omega Therapeutics, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Omega Therapeutics, Inc. News
11/17/24 Omega Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line
11/14/24 Omega Therapeutics, Inc. (OMGA) Reports Q3 Loss, Tops Revenue Estimates
11/14/24 Omega Therapeutics Announces Successful Completion of Phase 1 Trial for Novel Epigenomic Controller, Prioritized Pipeline, Leadership Changes, and Third Quarter 2024 Financial Results
10/29/24 Oculis Holding AG (OCS) Moves 7.9% Higher: Will This Strength Last?
10/23/24 Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence
10/15/24 Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings
10/03/24 Invaio Sciences Appoints André Andonian as Chairman of the Board of Directors
09/17/24 Omega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature Communications
08/14/24 Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research
08/06/24 Omega Therapeutics, Inc. (OMGA) Reports Q2 Loss, Tops Revenue Estimates
08/06/24 Omega Therapeutics Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress
08/06/24 Flagship Pioneering Announces Appointment of Raj Panjabi as Senior Partner
06/24/24 Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors
06/19/24 Nurix Therapeutics (NRIX) Surges 20.6%: Is This an Indication of Further Gains?
05/30/24 Omega Therapeutics To Participate In Two Upcoming Investor Conferences
05/29/24 Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer
05/08/24 Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers
05/07/24 Omega Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line
05/06/24 Omega Therapeutics, Inc. (OMGA) Reports Q1 Loss, Tops Revenue Estimates
05/06/24 Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
OMGA Chatroom

User Image mankind1 Posted - 1 hour ago

$OMGA time to load up!!

User Image Jizzle14 Posted - 3 hours ago

$OMGA down 40% in the last 30 days.

User Image mpap_ Posted - 3 hours ago

$OMGA Slowly but surely DCAing again. My take on this is the Novo Nordisk collaboration is undervalued here. OTX-2002 success would have been nice but is what it is. They are actively engaged in collaboration/licensing/partnerships with multiple companies per their press release and November corporate deck. Depending upon the terms could ignite the stock price again. Hoping I don't eat my words here and they just end up going bankrupt but time will tell.

User Image MSU1980 Posted - 10 hours ago

$OMGA Did any of the participants in OTX-2002 Phase 1 trial who were “stable” show an increase in their survival rate/life expectancy? Since HCC patients have a short life expectancy and the trial took 2 full years I would expect some data on how long the 14 patients who were stable lived versus the 14 patients who were no change woulld be available. My guess is there was no difference since the company declined to enter Phase 2 but would be good to know..

User Image biokvint Posted - 1 day ago

$OMGA started a position here….

User Image Rivahdog Posted - 2 days ago

$OMGA penny stock now. Delist and pink sheets next

User Image dirkfrank Posted - 2 days ago

$OMGA

User Image Frelseren Posted - 3 days ago

$OMGA $0,00 pre-marked?

User Image RealErnFranklin Posted - 3 days ago

$OMGA fans looking for some wins $LICY bullish $wisa hearing $20 Monday premarket $zone is the trade. Get playing fingers ready and sorry about getting up early. 💥

User Image Jizzle14 Posted - 6 days ago

$OMGA Anyone know what the personal reasons for why the CEO (Karande) left? https://www.marketwatch.com/story/omega-therapeutics-names-kaan-certel-as-ceo-bb3b77c6

User Image Jizzle14 Posted - 6 days ago

$OMGA Hedge funds and other institutional investors own 97.47% of the company's stock.

User Image RallyRaider Posted - 6 days ago

$OMGA geezus

User Image Jmstys245 Posted - 6 days ago

$OMGA $3 soon

User Image mpap_ Posted - 6 days ago

@Jmstys245 @GXD_Texas @Tortoise_Trader I literally have tens of thousands of shares of $OMGA and have been long it now for 2 years. I'm not a paid shill I am just being real about the company. My previous account got banned on here, Ive been posting on stocktwits for this stock now for 2 years.

User Image CipherGain Posted - 6 days ago

$OMGA 3$

User Image dirkfrank Posted - 6 days ago

$OMGA

User Image Jmstys245 Posted - 6 days ago

$OMGA no one even knows why going down? They r ripping this to $3 soon mark my words

User Image Jmstys245 Posted - 6 days ago

$OMGA Mpap is a paid bot/shill here for a reason. We are ripping to $3 probly next week honestly

User Image Jmstys245 Posted - 6 days ago

$OMGA don’t listen to these paid bots and shills. This things ripping to $3 probly next week

User Image mpap_ Posted - 6 days ago

$OMGA Yikes, were getting torched. Well been fun but seems like my money is basically lit on fire now. Not sure how this stock will recover.

User Image anachartanalyst Posted - 6 days ago

$OMGA https://anachart.com/wp-content/uploads/ana_temp/1731679317_soc-img.jpg

User Image Jmstys245 Posted - 6 days ago

$OMGA $5+ soon just wait…..

User Image justiceforb_85 Posted - 6 days ago

$OMGA little information on clinical efficacy of OTX-2002 in HCC. Hopefully in time they can release data on measures including biomarkers (AFP) and survival.

User Image Jmstys245 Posted - 1 week ago

$OMGA this will be $5 + very soon you heard it first here

User Image mpap_ Posted - 1 week ago

$OMGA A lot to unpack from the Q3 update. First and foremost CEO and CSO appointments. Mahesh leaving. Seems they are in talks with probably Roche to license OTX-2002 for Phase 2 trials in collaboration. More then likely this may get discontinued if they do not get funding or partnership does not go through. Changeup in Pre-clinical focus's with 3 chosen focuses: Obesity - collaboration with Novo Nordisk Regenerative Medicine - HNF4A - Mash Metabolic - FGF21 - Target https://ir.omegatherapeutics.com/news-releases/news-release-details/omega-therapeutics-announces-successful-completion-phase-1-trial

User Image Jmstys245 Posted - 1 week ago

$OMGA yall will be sorry when we wake up and this is at $3+

User Image dirkfrank Posted - 1 week ago

$OMGA

User Image Civfreak1 Posted - 1 week ago

$OMGA

User Image mpap_ Posted - 1 week ago

$OMGA More Pre-Clinical Data for treatment β- and α-Thalassemia https://omegatherapeutics.com/wp-content/uploads/2024/11/OMGA_mRNA_Health_2024_Poster-vFINAL.pdf

User Image Tortoise_Trader Posted - 1 week ago

$OMGA how do you guys invest in bio cause I hate it here

Analyst Ratings
HC Wainwright & Co. Buy Aug 15, 24
Wedbush Outperform Aug 7, 24
Chardan Capital Buy Aug 7, 24
Raymond James Outperform Jun 18, 24
HC Wainwright & Co. Buy May 13, 24
Chardan Capital Buy May 7, 24
HC Wainwright & Co. Buy Apr 30, 24
Piper Sandler Overweight Apr 3, 24
Chardan Capital Buy Apr 1, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Flagship Pioneering Inc. 10% Owner 10% Owner Feb 27 Buy 5.78 3,323,310 19,208,732 1,329,324 02/27/23
Young Richard A Director Director Sep 14 Sell 8.00 10,000 80,000 784,118 09/15/22